Janelle Barowski, MSN RN

Researchers examined factors associated with antibiotic prescribing among older adults infected with COVID-19.

Researchers evaluated the burden and clinical characteristics of severe RSV-associated pneumonia among adult patients.

Researchers evaluated the risk for household COVID-19 transmission among adults and children with prior infection-induced immunity.

Researchers assessed the effects of convalescent vs control plasma on time to symptom resolution among patients with COVID-19 infection.

Researchers evaluated risk factors associated with persistent COVID-19 symptoms at 28 and 90 days following infection onset.

Researchers compared the risk for prolonged symptoms following COVID-19 infection among individuals infected during the pre-Delta, Delta, and Omicron periods.

Researchers evaluated the effectiveness and safety of COVID-19 vaccination during pregnancy.

Researchers evaluated national action plans on efforts to control antimicrobial resistance across 114 countries.

Researchers evaluated changes in menstruation following COVID-19 vaccination.

Researchers assessed the association between rates of COVID-19 vaccination among nursing home staff and COVID-19 outcomes among staff and residents.

Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.

Researchers evaluated associations between various antihyperglycemic medications and the risk for COVID-19-related adverse outcomes in patients with diabetes.

Researchers evaluated the efficacy and safety of favipiravir among patients hospitalized with COVID-19.

Researchers evaluated the safety and efficacy of ensitrelvir for the treatment of mild to moderate COVID-19 infection during the Omicron wave.

Researchers compared the presence of symptoms 2 years after acute COVID-19 infection between hospitalized and nonhospitalized patients.

Researchers evaluated the short-term safety profile of a second booster dose of a COVID-19 mRNA vaccine.

Researchers evaluated the effectiveness of bivalent mRNA COVID-19 vaccination among adults who previously received at least 2 monovalent vaccine doses.